Blue Edge Capital, LLC XBI Holdings History
Blue Edge Capital, LLC's SPDR Biotech ETF Holding Summary
As of 2025-03-31, Blue Edge Capital, LLC held 5,377.00 shares of SPDR Biotech ETF(XBI), totaling $436,080.00. This investment constitutes 0.07% of their stock portfolio, and Blue Edge Capital, LLC now holds 0.01% of the outstanding SPDR Biotech ETF(XBI) stock.
The initial trade took place in 2024Q1. And since then Blue Edge Capital, LLC has made 2 purchases of XBI, at an average price of $94.35, for a total of 22,302.00 shares. In addition, there have been 1 sales at an average price of $93.17 for 11,309.00 shares. Based on historical transaction data and XBI's current price of $86.27, Blue Edge Capital, LLC's estimated gain on his XBI holdings is $-102,297.34, reflecting a -4.86% gain to date.
Blue Edge Capital, LLC XBI ($86.27) Holding Chart
Blue Edge Capital, LLC XBI ($86.27) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
